Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline.
Humera KhurshidNofisat IsmailaJessica BianRaetasha DabneyMillie DasPeter Michael EllisJill FeldmanChristine L HannSwati KulkarniJanessa LaskinRami ManochakianDeebya Raj MishraIsabel R PreeshagulPavan S ReddyAshish SaxenaFrank WeinbergGregory P KalemkerianPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Evidence-based recommendations were developed to address systemic therapy options, timing of therapy, treatment in patients who are older or with poor performance status, role of biomarkers, and use of myeloid-supporting agents in patients with small-cell lung cancer.Additional information is available at www.asco.org/thoracic-cancer-guidelines.
Keyphrases
- small cell lung cancer
- healthcare
- public health
- clinical practice
- brain metastases
- health information
- papillary thyroid
- acute myeloid leukemia
- physical activity
- mental health
- dendritic cells
- stem cells
- squamous cell carcinoma
- mesenchymal stem cells
- middle aged
- social media
- risk assessment
- drug induced
- replacement therapy
- chemotherapy induced